Clinical Trials Logo

Intensive Care clinical trials

View clinical trials related to Intensive Care.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04554264 Withdrawn - Covid19 Clinical Trials

Complicated Grief in ICU in the Aftermath of COVID-19

DEPARTS
Start date: September 1, 2020
Phase: N/A
Study type: Interventional

An increased proportion of deaths occur in the intensive care unit (ICU). Some amenable factors such as end-of-life practices may contribute to complicated grief. Because of the COVID-19 pandemic, visitor restrictions in health care facilities have been implemented. Families were also unable to implement usual funerals. The investigators hypothesize that these policies and practices may impact grief during covid-19 pandemic. The aim of this study is to evaluate the prevalence of complicated grief after death of a relative in the ICU during the COVID-19 pandemic.

NCT ID: NCT01749488 Withdrawn - Intensive Care Clinical Trials

The Impact of a Dietitian in the Implementation of Nutrition Recommendations During Intensive Care

NutriSave
Start date: October 2015
Phase: N/A
Study type: Interventional

The main objective of this study is to evaluate the impact of the intervention of a dietician on the energy balance accumulated over seven days of intensive care. Energy balance is defined as the difference between the target recommended energy and total calorie intake actually received. This is a randomized-cluster study; participating centers are randomized into experimental and control groups.

NCT ID: NCT00987818 Withdrawn - Sepsis Clinical Trials

Procalcitonin Guided Versus Conventional Antibiotic Therapy in Patients With Sepsis in the ICU

Start date: n/a
Phase: N/A
Study type: Interventional

The adequacy of early empiric antimicrobial therapy is an important factor in determining the outcome in patients with severe sepsis. The duration of adequate antibiotic therapy in these patients however is less clear. Duration of antibiotic therapy in patients with sepsis in the ICU based on inflammatory markers has not been extensively studied. Procalcitonin (PCT) is an acute phase protein that has prognostic value in critically ill patients and can be used to monitor disease activity in sepsis and systemic inflammation. This study will examine the effect of PCT guided antibiotic therapy compared with conventional antibiotic therapy on treatment duration in patients with sepsis admitted to the ICU.

NCT ID: NCT00878683 Withdrawn - Intensive Care Clinical Trials

Novel Device for Reducing Catheter-Related Infections

Start date: July 2009
Phase: N/A
Study type: Interventional

This study is a pilot study of the safety, tolerability and efficacy of an investigational central venous catheter device used in conjunction with a standard central venous catheter. The hypothesis is that utilization of a catheter device incorporating cyanoacrylate will reduce catheter colonization by bacteria, and may decrease the rate of catheter-related bloodstream infections.